Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors

• by Amr Elgehiny, Aaron E. Fan, Maria Frost, Jiasen He, Sam E. Gary, Diana S. Osorio, Wafik Zaky, Li Zhou, Kyung-Don Kang, Zhuo Zhang, Juan Fueyo, Candelaria Gomez-Manzano, Eric M. Thompson, Joshua D. Bernstock, Gregory K. Friedman

• February 25, 2026

Dana Farber/Boston Children’s Researchers Uncover Distinct Tumor “neighborhoods” with Each Cell Subtype Playing a Specific Role, in Aggressive Childhood Brain Cancer

Their detailed blueprint of tumor cell diversity could guide more precise, targeted treatments for supratentorial ependymomas 

• by

• March 12, 2026

• 3 min

Can This Device Help Neurosurgeons Better Treat Normal Pressure Hydrocephalus — and More?

A Keck Medicine of USC neurointerventionalist discusses how a minimally invasive, endovascularly implantable cerebrospinal fluid shunt is the next-generation treatment for normal pressure hydrocephalus — and possibly more.

• by

• March 30, 2026

• 4 min

Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases

• by Fabien Boux, Alexis Mercier, Daniela Talba, Jean-Yves Giraud, Sandrine Dufort, Khalide Seddik, Sylvie Grand, Mélanie Gataleta, Alexandre Leboucher, Johan Pietras, Olivier De Beaumont, Géraldine Le Duc, Camille Verry

• April 4, 2026